1-9 of 9
Michael A. Linden
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phenotypic and Functional Characterization of Multiple Myeloma By Single Cell Mass Cytometry (CyTOF)

Linda B Baughn, PhD, Erik Jessen, PhD, Matthew Smith, Neeraj Sharma, PhD, Joselle Cook, MBBS, Surendra Dasari, PhD, Kathryn E. Pearce, MS, Nathalie Meurice, PhD, Michael A. Linden, MDPhD, A. Keith Stewart, MB, ChB, P. Leif Bergsagel, MD, Brian G. Van Ness, PhD, Shaji K. Kumar, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-141639
Published: 2020
Journal Articles

Romiplostim Improves Platelet Recovery after UCB Transplant

Georgios E. Christakopoulos, MD, Todd E. DeFor, MS, Stefanie M Hage, RN, John E. Wagner, MD, Michael A. Linden, MD PhD, Claudio G Brunstein, MD PhD, Nelli Bejanyan, MD, Michael R Verneris, MD, Angela R. Smith, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 1979.
https://doi.org/10.1182/blood-2019-125424
Published: 2019
Journal Articles

Single-Cell Transcriptional Profiling of Acute Myeloid Leukemia Identifies Prognostic Transcriptional Profiles at Diagnosis

Karen Sachs, PhD, Aaron Sarver, PhD, Klara Noble-Orcutt, Connor Navis, Alexandria Hillesheim, Ian Nykaza, Rebecca S. Larue, PhD, Conner Hansen, Nuri Temiz, Ngoc Ha, Michael A. Linden, MDPhD, David A. Largaespada, PhD, Zohar Sachs, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2704.
https://doi.org/10.1182/blood.V130.Suppl_1.2704.2704
Published: 2017
Journal Articles

The Effect of Measurable Residual Disease at the Time of Allogeneic Hematopoietic Cell Transplantation on Outcomes in Patients with Acute Myeloid Leukemia: A Meta-Analysis

Sarah A. Buckley, MD, Brent L. Wood, MD PhD, Megan Othus, PhD, Christopher S. Hourigan, MD PhD, Celalettin Ustun, MD, Michael A. Linden, MD PhD, Todd E. DeFor, MS, Michele Malagola, MD PhD, Christopher G. Kanakry, MD, Bernd Gruhn, MD, Beth Devine, PhD PharmD, Roland B. Walter, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2842.
https://doi.org/10.1182/blood.V128.22.2842.2842
Published: 2016
Journal Articles

Single-Cell Transcriptomics Identifies Intra-Tumor Heterogeneity in Human Myeloma Cell Lines

Amit Kumar Mitra, PhD, Holly Stessman, PhD, Michael A. Linden, MDPhD, Brian Van Ness, PhD
Journal: Blood
Blood (2014) 124 (21): 3385.
https://doi.org/10.1182/blood.V124.21.3385.3385
Published: 2014
Journal Articles

Bortezomib Is Highly Effective For Pure Red Cell Aplasia After ABO-Incompatible Hematopoietic Stem Cell Transplantation

Fatima Khan, MBBS, Michael A. Linden, MD, PhD, Nicole D. Zantek, M.D., Ph.D., Gregory M Vercellotti
Journal: Blood
Blood (2013) 122 (21): 5495.
https://doi.org/10.1182/blood.V122.21.5495.5495
Published: 2013
Journal Articles

Autologous and Allogeneic Donor Transplantation for Mantle Cell Lymphoma in Rituximab Era: Impact of Pre-Transplant Burden On Survival.

Erik A Magnusson, MS, Qing Cao, MS, Michael A. Linden, MD, PhD, Linda J Burns, MD, Daniel J. Weisdorf, MD, Veronika Bachanova, MD
Journal: Blood
Blood (2012) 120 (21): 3092.
https://doi.org/10.1182/blood.V120.21.3092.3092
Published: 2012
Journal Articles

Targeted Overexpression of Mutant Activated N- ras Leads to Aberrant Plasma Cell Biology.

Michael A. Linden, PhD, Nicole Kirchhof, DVM, Brian G. Van Ness, PhD
Journal: Blood
Blood (2004) 104 (11): 1416.
https://doi.org/10.1182/blood.V104.11.1416.1416
Published: 2004
Journal Articles

Gene profiling of a myeloma cell line reveals similarities and unique signatures among IL-6 response, N- ras -activating mutations, and coculture with bone marrow stromal cells

Paula A. Croonquist, Michael A. Linden, Fangyi Zhao, Brian G. Van Ness
Journal: Blood
Blood (2003) 102 (7): 2581–2592.
https://doi.org/10.1182/blood-2003-04-1227
Published: 2003
Includes: Supplemental data